Attached files
file | filename |
---|---|
EX-5.1 - EX-5.1 - Spero Therapeutics, Inc. | d521849dex51.htm |
EX-3.3 - EX-3.3 - Spero Therapeutics, Inc. | d521849dex33.htm |
EX-1.1 - EX-1.1 - Spero Therapeutics, Inc. | d521849dex11.htm |
S-1/A - S-1/A - Spero Therapeutics, Inc. | d521849ds1a.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 1 to the Registration Statement on Form S-1 of Spero Therapeutics, Inc. of our report dated April 2, 2018 relating to the financial statements of Spero Therapeutics, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
July 11, 2018